MA52793A - Agent antitumoral et méthode de traitement d'une tumeur - Google Patents
Agent antitumoral et méthode de traitement d'une tumeurInfo
- Publication number
- MA52793A MA52793A MA052793A MA52793A MA52793A MA 52793 A MA52793 A MA 52793A MA 052793 A MA052793 A MA 052793A MA 52793 A MA52793 A MA 52793A MA 52793 A MA52793 A MA 52793A
- Authority
- MA
- Morocco
- Prior art keywords
- tumor
- treatment method
- agent
- tumor treatment
- tumor agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862677379P | 2018-05-29 | 2018-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52793A true MA52793A (fr) | 2021-04-14 |
Family
ID=68698132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052793A MA52793A (fr) | 2018-05-29 | 2019-05-28 | Agent antitumoral et méthode de traitement d'une tumeur |
Country Status (6)
Country | Link |
---|---|
US (1) | US12036215B2 (fr) |
EP (1) | EP3804721A4 (fr) |
JP (1) | JP7227968B2 (fr) |
MA (1) | MA52793A (fr) |
TW (1) | TWI813694B (fr) |
WO (1) | WO2019230679A1 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI485146B (zh) * | 2012-02-29 | 2015-05-21 | Taiho Pharmaceutical Co Ltd | Novel piperidine compounds or salts thereof |
US9012475B2 (en) | 2013-08-27 | 2015-04-21 | Taiho Pharmaceutical Co., Ltd. | Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor |
TWI693218B (zh) | 2014-11-14 | 2020-05-11 | 美商美國禮來大藥廠 | 極光a激酶抑制劑 |
CN110088097A (zh) | 2016-12-22 | 2019-08-02 | 大鹏药品工业株式会社 | 取代的哌啶化合物的盐 |
-
2019
- 2019-05-28 TW TW108118382A patent/TWI813694B/zh active
- 2019-05-28 MA MA052793A patent/MA52793A/fr unknown
- 2019-05-28 US US17/059,376 patent/US12036215B2/en active Active
- 2019-05-28 EP EP19810105.7A patent/EP3804721A4/fr active Pending
- 2019-05-28 WO PCT/JP2019/020992 patent/WO2019230679A1/fr unknown
- 2019-05-28 JP JP2020522194A patent/JP7227968B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP3804721A4 (fr) | 2022-03-16 |
TW202015680A (zh) | 2020-05-01 |
WO2019230679A1 (fr) | 2019-12-05 |
JP7227968B2 (ja) | 2023-02-22 |
EP3804721A1 (fr) | 2021-04-14 |
US12036215B2 (en) | 2024-07-16 |
JPWO2019230679A1 (ja) | 2021-05-20 |
TWI813694B (zh) | 2023-09-01 |
US20210236475A1 (en) | 2021-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272137A (en) | Mutations of interleukin-21 and methods of treatment | |
IL280707A (en) | Diagnostic and therapeutic methods for treating breast cancer | |
MX2019007648A (es) | Composiciones y metodos para la induccion de celulas t cd8+. | |
MA47310A (fr) | Combinaisons de cabozantinib et d'atzolizumab pour traiter le cancer | |
MX2018011114A (es) | Métodos y composiciones relacionadas con crispr/cas para el tratamiento de beta hemoglobinopatías. | |
MA56212A (fr) | Compositions et méthodes de traitement du cancer | |
MX2020001774A (es) | Composiciones y métodos para tratar enfermedad colestásica. | |
BR112019002331A2 (pt) | anticorpos anti-siglec-7 para o tratamento do câncer e métodos para obtenção dos mesmos | |
MX2020005567A (es) | Metodos de tratamiento con asparaginasa. | |
MA47613A (fr) | Compositions et procédés de traitement du cancer | |
MA49059A (fr) | Traitement des cancers positifs à her2 | |
MA55143A (fr) | Composés aryl-aniline et hétéroaryl-aniline pour le traitement de cancers de la peau | |
MA52627A (fr) | Traitement du cancer | |
SG11202010793UA (en) | Methods of treating cancer | |
MA51678A (fr) | Méthodes de traitement de l'amyotrophie musculaire | |
IL276203A (en) | Compounds and methods for treating cancer | |
IL272810A (en) | Methods for diagnosing and treating lung cancer | |
IL279591A (en) | Cancer treatment methods using combination therapy | |
IL277981A (en) | Cancer treatment methods | |
MX2023007680A (es) | Metodos de tratamiento y terapia de mantenimiento para el cancer de vejiga con gemcitabina. | |
MA51295A (fr) | Dosage, procédé et traitement d'alpha-synucléinopathies | |
IL281600A (en) | Methods of treating cancer | |
EA201991927A1 (ru) | Новый иммуностимулирующий макролид | |
MA55093A (fr) | Méthodes et compositions pour le traitement du cancer | |
MA52793A (fr) | Agent antitumoral et méthode de traitement d'une tumeur |